BIOMAT Database Logo BIOMAT Database Logo

Optimizing remission rates using antithyroid drugs for Graves' disease. 2010

Laszlo Hegedüs
Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark. laszlo.hegedus@ouh.regionsyddanmark.dk

UI MeSH Term Description Entries
D011193 Potassium Iodide An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed) Antistrumin,Ioduro Potasico Rovi,Iosat,Jod beta,Jodetten Henning,Jodgamma,Jodid,Jodid Hexal,Jodid Verla,Jodid dura,Jodid-ratiopharm,Mono-Jod,Pima,SSKI,Thyro-Block,Thyroprotect,Iodide, Potassium,Jodid ratiopharm,Mono Jod,Thyro Block
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013956 Antithyroid Agents Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. Antithyroid Agent,Antithyroid Drug,Goitrogen,Goitrogens,Thyroid Antagonists,Antithyroid Drugs,Antithyroid Effect,Antithyroid Effects,Agent, Antithyroid,Agents, Antithyroid,Antagonists, Thyroid,Drug, Antithyroid,Drugs, Antithyroid,Effect, Antithyroid,Effects, Antithyroid
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Laszlo Hegedüs
Remission rates with antithyroid drugs.
February 1988, Annals of internal medicine,
Laszlo Hegedüs
Synthetic antithyroid drugs and Graves' disease.
February 1949, Le Progres medical,
Laszlo Hegedüs
Antithyroid drugs--a rational treatment for Graves' disease?
January 1987, Hormone research,
Laszlo Hegedüs
Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.
March 1991, Journal of the National Medical Association,
Laszlo Hegedüs
How antithyroid drugs work in Graves' disease.
October 1992, Clinical endocrinology,
Laszlo Hegedüs
Prediction of remission after antithyroid drug treatment in Graves' disease.
February 1988, The Quarterly journal of medicine,
Laszlo Hegedüs
DISEASE PRESENTATION AND REMISSION RATE IN GRAVES DISEASE TREATED WITH ANTITHYROID DRUGS: IS GENDER REALLY A FACTOR?
January 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Laszlo Hegedüs
The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
January 1974, Clinical endocrinology,
Laszlo Hegedüs
Treatment of Graves' disease with antithyroid drugs: current perspectives.
September 2010, Thyroid : official journal of the American Thyroid Association,
Laszlo Hegedüs
Has the use of antithyroid drugs for Graves' disease become obsolete?
January 1993, Thyroid : official journal of the American Thyroid Association,
Copied contents to your clipboard!